Disease insights, diagnosis, and monitoring

Understanding and defining the characteristics of retinal diseases are crucial steps to ensuring optimal diagnosis and treatment. However, early and accurate diagnosis of retinal diseases presents a key challenge for ophthalmologists, as there are often no standardized guidelines on the correct assessment methods to employ. Clinical decisions should be guided by disease characteristics and should aim to achieve an optimal outcome. We aim to provide insights into disease characteristics, as well as guidance on clinically challenging situations associated with diagnosis and monitoring.


Treatment and management

Providing care that considers the individual patient’s preferences and needs should be at the forefront of clinical decision-making. The ophthalmic community should be driven by patient values, with the patient placed centrally in the treatment decision pathway. Nonetheless, there are many disease complexities that require nuanced treatment and management. We aim to provide guidance that enables ophthalmologists to navigate these clinically challenging situations.



The lasting impacts of the COVID-19 pandemic have resulted in ongoing changes to clinical practice. We, in conjunction with the nAMD Barometer, have developed a range of materials to ensure ophthalmologists feel supported in making appropriate treatment decisions and to help patients better understand the safety measures put in place. These tools have been designed to be appropriate across a range of epidemic pressures and are available in multiple languages.